ARCH Venture
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
76Deep-tech portfolio66 active
8Portfolio exitsAcquired or listed
5Raises, 12 monthsLatest: Moonwalk Biosciences
72Co-investorsShare a portfolio company
Portfolio companies’ first raises and first grants, by year
First raisesFirst federal grants
The year each portfolio company first filed a Form D, and first won a federal grant. These describe the companies, not when this investor joined them.
Portfolio · 76 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Moonwalk Biosciences | Biotech | Active | Sep 14, 2026 | $109.6M |
| SonoThera | Biotech | Active | Jun 30, 2026 | $155.8M |
| Lycia Therapeutics | Biotech | Active | Jun 25, 2026 | $277.0M |
| Gilgamesh Pharma | Biotech | Active | Mar 31, 2026 | $68.3M |
| Vizgen | Medtech | Active | Jan 12, 2026 | $295.1M |
| Basking Biosciences | Biotech | Active | Oct 22, 2025 | $29.4M |
| Pheast Therapeutics | Biotech | Active | Oct 16, 2025 | $49.8M |
| Dewpoint Therapeutics | Biotech | Active | Sep 23, 2025 | $286.2M |
| Volastra Therapeutics | Biotech | Active | Sep 23, 2025 | $105.3M |
| Treeline Biosciences | Biotech | Active | Sep 4, 2025 | $1.1B |
| PsiQuantum | Quantum | Active | May 30, 2025 | $22.0M |
| Arsenal Biosciences | Biotech | Active | Sep 4, 2024 | $579.2M |
| Colossal Biosciences | Biotech | Active | Jul 23, 2024 | $150.0M |
| Slingshot Biosciences | Biotech | Active | Apr 26, 2024 | $23.6M |
| Skylark Bio | Biotech | Active | Apr 19, 2024 | $22.9M |
| Mirador Therapeutics | Biotech | Active | Apr 3, 2024 | $413.0M |
| eGenesis | Biotech | Active | Feb 27, 2024 | $265.0M |
| Elephas Biosciences | Medtech | Active | Jan 9, 2024 | $113.7M |
| Remix Therapeutics | Biotech | Active | Jan 4, 2024 | $13.7M |
| Neumora Therapeutics | Medtech | Active | Jan 3, 2023 | $474.4M |
| Synchron | Medtech | Active | Dec 20, 2022 | $82.5M |
| hC Bioscience | Biotech | Active | Nov 1, 2022 | $12.0M |
| AIRNA | Biotech | Active | Nov 24, 2021 | $1K |
| Arbor Biotechnologies | Biotech | Active | Nov 10, 2021 | $227.2M |
| Nutcracker Therapeutics | Biotech | Active | Sep 7, 2021 | $172.5M |
| Sonoma Biotherapeutics | Biotech | Active | Aug 11, 2021 | $265.0M |
| National Resilience | Biotech | Active | Jan 6, 2021 | $755.0M |
| Peptilogics | Biotech | Active | Dec 30, 2020 | $40.9M |
| Sana Biotechnology | Biotech | Active | Jun 26, 2020 | $866.9M |
| Insitro | Biotech | Active | May 27, 2020 | $143.2M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| LifeMine Therapeutics | Biotech | Active | Mar 29, 2019 | $30.1M |
| KSQ Therapeutics | Biotech | Active | Oct 1, 2018 | $80.6M |
| Aera Therapeutics | Biotech | Active | — | — |
| Altos Labs | Biotech | Active | — | — |
| Appia Bio | Biotech | Active | — | — |
| Aspen Neuroscience | Biotech | Active | — | — |
| BE Biopharma | Biotech | Active | — | — |
| Bitterroot Bio | Biotech | Active | — | — |
| City Therapeutics | Biotech | Active | — | — |
| Dispatch Biotherapeutics | Biotech | Active | — | — |
| Encoded Therapeutics | Biotech | Active | — | — |
| Freethink | Clean tech | Active | — | — |
| Gate Bioscience | Biotech | Active | — | — |
| Generate Biomedicines | Biotech | Active | — | — |
| HiberCell | Biotech | Active | — | — |
| Inograft Biotherapeutics | Biotech | Active | — | — |
| Jaguar Gene Therapy | Biotech | Active | — | — |
| Lilac Therapeutics | Biotech | Active | — | — |
| Magnet Biomedicine | Biotech | Active | — | — |
| Maze Therapeutics | Biotech | Active | — | — |
| Mozart Therapeutics | Biotech | Active | — | — |
| Myeloid Therapeutics | Biotech | Active | — | — |
| nChroma Bio | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
| Paratus Sciences | Biotech | Active | — | — |
| Pretzel Therapeutics | Biotech | Active | — | — |
| Rapport Therapeutics | Biotech | Active | — | — |
| Scale Biosciences | Biotech | Active | — | — |
| Singular Genomics Systems | Medtech | Active | — | — |
| Tenvie | Biotech | Active | — | — |
| Trotana Therapeutics | Biotech | Active | — | — |
| Vesalius Therapeutics | Biotech | Active | — | — |
| Vilya | Biotech | Active | — | — |
| Walden Biosciences | Biotech | Active | — | — |
| Xaira Therapeutics | Biotech | Active | — | — |
| Areteia Therapeutics | Biotech | Closed | Feb 21, 2025 | $175.0M |
| Seaport Therapeutics | Biotech | Public | Oct 31, 2024 | $225.9M |
| Quantum Circuits | Quantum | Acquired | May 2, 2024 | $26.6M |
| Denali Therapeutics | Biotech | Public | Mar 1, 2024 | $499.7M |
| Voyager Therapeutics | Biotech | Public | Jan 17, 2024 | $119.0M |
| Fate Therapeutics | Biotech | Public | Jul 6, 2020 | $235.8M |
| Unity Biotechnology | Biotech | Closed | Mar 27, 2018 | $165.7M |
| IonQ | Quantum | Public | Jul 27, 2017 | $14.0M |
| Prime Medicine | Biotech | Public | — | — |
| ROME Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#3
Portfolio exits#20
Raises, 12 months#3
Co-investors#8
Co-investors
- Foresite CapitalVenture capital8 shared
- Third Rock VenturesVenture capital6 shared
- RA CapitalVenture capital5 shared
- Andreessen HorowitzVenture capital4 shared
- Flagship PioneeringVenture capital4 shared
- F-Prime CapitalVenture capital4 shared
- Mission BioCapitalVenture capital4 shared
- Atlas VentureVenture capital3 shared
- Cormorant Asset ManagementVenture capital3 shared
- GVVenture capital3 shared
Sectors
- Biotech67
- Medtech5
- Quantum3
- Clean tech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.